Project Details
Description
Assessing Novel Rexinoids Developed by Comparative Bioresponse Analysis in an Innovative Mouse Model of Cutaneous T Cell Lymphoma Assessing Novel Rexinoids Developed by Comparative Bioresponse Analysis in an Innovative Mouse Model of Cutaneous T Cell Lymphoma
| Status | Active |
|---|---|
| Effective start/end date | 5/1/20 → 4/30/23 |
Funding
- HHS: National Institutes of Health (NIH): $484,166.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.